PAA3 A BUDGET IMPACT MODEL FOR DETERMINING THE COSTS OF INTRODUCING A NEW EXTRAFINE COMBINATION (BECLOMETHASONE/FORMOTEROL) FOR THE TREATMENT OF MODERATE TO SEVERE PERSISTENT ASTHMA IN SPAIN | Publicación